Use of methylphenidate and reporting of valvular heart disease: Global pharmacovigilance analysis in children and adults
E Ayme‐Dietrich, F Kaguelidou… - … and Drug Safety, 2024 - Wiley Online Library
Introduction Methylphenidate (MPH) is a common treatment of attention‐deficit/hyperactivity
disorder (ADHD). Concern has been raised regarding its cardiovascular safety, partly in …
disorder (ADHD). Concern has been raised regarding its cardiovascular safety, partly in …
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder: A Case Series
AC Westerkamp, RR Pereira, VR Huitema… - Journal of Clinical …, 2024 - journals.lww.com
Purpose/Background: Methylphenidate (MPH) is widely used to reduce symptoms of
attention-deficit/hyperactivity disorder. Methylphenidate is metabolized by the …
attention-deficit/hyperactivity disorder. Methylphenidate is metabolized by the …
[PDF][PDF] Tolerability of Chronic Extremely High-dose Use of Methylphenidate. Description of A Clinical Case
MC Rosenhagen, F Vandenberghe… - J Med-Clin Res & …, 2023 - researchgate.net
Methylphenidate (MPH) is frequently employed off-label and at high uncontrolled dosages,
even beyond the scope of attention deficit hyperactivity disorder (ADHD) treatment …
even beyond the scope of attention deficit hyperactivity disorder (ADHD) treatment …